EXTRA-STRENGTH BISMUTH 35 MG
BISMUTH SUBSALICYLATE : 35 MG · DIN 02242537 · PERRIGO INTERNATIONAL
Health Canada status: CANCELLED POST MARKET
What is EXTRA-STRENGTH BISMUTH?
EXTRA-STRENGTH BISMUTH 35 MG contains BISMUTH SUBSALICYLATE : 35 MG. It is listed in the Health Canada Drug Product Database under DIN 02242537, held by PERRIGO INTERNATIONAL, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Jan-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242537 |
|---|---|
| Brand name | EXTRA-STRENGTH BISMUTH |
| Generic / active ingredient | BISMUTH SUBSALICYLATE : 35 MG |
| Manufacturer | PERRIGO INTERNATIONAL |
| Strength | 35 MG |
| Dosage form | SUSPENSION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BB BISMUTH PREPARATIONS |
| AHFS class | 56:04.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Jan-2019 |
| Original market date | 2000-11-21 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02242537 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2242537 |
| Brand name | EXTRA-STRENGTH BISMUTH |
| Active ingredient / INN | BISMUTH SUBSALICYLATE : 35 MG |
| ATC code | A07BB |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A07 |
| AHFS class | 56:04.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | PERRIGO INTERNATIONAL |
Which pack is which?
| Strength on the label | 35 MG |
|---|---|
| Dosage form | SUSPENSION |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A07BB BISMUTH PREPARATIONS. 12 of 55 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BISMUTH CAPLETS | 262 MG | TABLET | JUNO OTC INC | MARKETED | DIN 02457121 |
| BISMUTH SUBSALICYLATE CAPLETS | 262 MG | TABLET | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02326582 |
| BISMUTH SUBSALICYLATE SUSPENSION | 17.5 MG | SUSPENSION | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02313162 |
| EXTRA STRENGTH BISMUTH | 35.2 MG | SUSPENSION | JUNO OTC INC | MARKETED | DIN 02475855 |
| EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION | 35 MG | SUSPENSION | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02328453 |
| GASTROVOL LIQUID GELS | 262 MG | CAPSULE | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02534436 |
| PEPTO BISMOL CAPLET - 262MG/CAPLET | 262 MG | TABLET | PROCTER & GAMBLE INC | MARKETED | DIN 02177994 |
| PEPTO BISMOL LIQUICAPS | 262 MG | CAPSULE | PROCTER & GAMBLE INC | MARKETED | DIN 02499991 |
| PEPTO-BISMOL | 17.6 MG | SUSPENSION | PROCTER & GAMBLE INC | MARKETED | DIN 02097079 |
| PEPTO-BISMOL EXTRA | 35.2 MG | SUSPENSION | PROCTER & GAMBLE INC | MARKETED | DIN 02229668 |
Who else supplies BISMUTH PREPARATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BISMUTH PREPARATIONS appears in 13 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does BISMUTH PREPARATIONS cost around the world?
BISMUTH PREPARATIONS is listed on 2 national price registers Nexara tracks, across 3 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 1 | 2 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.